Barington/Hilco Acquisition (BHAC) - Net Assets
Based on the latest financial reports, Barington/Hilco Acquisition (BHAC) has net assets worth $4.11 Million USD as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.85 Million) and total liabilities ($9.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Barington/Hilco Acquisition asset portfolio for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.11 Million |
| % of Total Assets | 29.68% |
| Annual Growth Rate | 1.14% |
| 5-Year Change | 10.76% |
| 10-Year Change | N/A |
| Growth Volatility | 1595.29 |
Barington/Hilco Acquisition - Net Assets Trend (2015–2024)
This chart illustrates how Barington/Hilco Acquisition's net assets have evolved over time, based on quarterly financial data. Check Barington/Hilco Acquisition (BHAC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Barington/Hilco Acquisition (2015–2024)
The table below shows the annual net assets of Barington/Hilco Acquisition from 2015 to 2024. For live valuation and market cap data, see how much is Barington/Hilco Acquisition worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $5.54 Million | -75.34% |
| 2023-12-31 | $22.45 Million | -44.96% |
| 2022-12-31 | $40.79 Million | -81.20% |
| 2021-12-31 | $216.97 Million | +4239.45% |
| 2017-12-31 | $5.00 Million | 0.00% |
| 2016-12-31 | $5.00 Million | 0.00% |
| 2015-12-31 | $5.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Barington/Hilco Acquisition's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 725407100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.27 Million | 239.56% |
| Other Components | $410.00 | 0.01% |
| Total Equity | $5.54 Million | 100.00% |
Barington/Hilco Acquisition Competitors by Market Cap
The table below lists competitors of Barington/Hilco Acquisition ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eaton Vance Senior Income Closed Fund
NYSE:EVF
|
$90.31 Million |
|
Bon Fame Co Ltd
TWO:8433
|
$90.33 Million |
|
Micropolis Holding Company
NYSE MKT:MCRP
|
$90.36 Million |
|
OncoCyte Corp
NASDAQ:OCX
|
$90.37 Million |
|
DHI Group Inc
NYSE:DHX
|
$90.26 Million |
|
Edel SE & Co. KGaA
F:EDL
|
$90.20 Million |
|
Mercan Kimya Sanayi ve Ticaret AS
IS:MERCN
|
$90.14 Million |
|
Bioton S.A.
WAR:BIO
|
$90.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Barington/Hilco Acquisition's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 22,453,282 to 5,537,977, a change of -16,915,305 (-75.3%).
- Net loss of 5,275,000 reduced equity.
- Share repurchases of 11,692,068 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.28 Million | -95.25% |
| Share Repurchases | $11.69 Million | -211.13% |
| Other Changes | $51.76K | +0.93% |
| Total Change | $- | -75.34% |
Book Value vs Market Value Analysis
This analysis compares Barington/Hilco Acquisition's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.35x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 9.40x to 7.35x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $2.34 | $22.00 | x |
| 2016-12-31 | $2.34 | $22.00 | x |
| 2017-12-31 | $2.34 | $22.00 | x |
| 2021-12-31 | $7.55 | $22.00 | x |
| 2022-12-31 | $1.48 | $22.00 | x |
| 2023-12-31 | $2.22 | $22.00 | x |
| 2024-12-31 | $3.00 | $22.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Barington/Hilco Acquisition utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -95.25%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 2.48x
- Recent ROE (-95.25%) is below the historical average (-12.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -9.40% | -98.41% | 0.01x | 8.78x | $-970.00K |
| 2016 | -3.24% | -50.09% | 0.01x | 8.79x | $-662.00K |
| 2017 | -38.62% | -84.10% | 0.15x | 2.97x | $-2.43 Million |
| 2021 | 5.73% | 0.00% | 0.00x | 1.08x | $-9.27 Million |
| 2022 | 18.79% | 361.09% | 0.04x | 1.26x | $3.59 Million |
| 2023 | 35.08% | 0.00% | 0.00x | 1.13x | $5.63 Million |
| 2024 | -95.25% | 0.00% | 0.00x | 2.48x | $-5.83 Million |
Industry Comparison
This section compares Barington/Hilco Acquisition's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $131,731,145
- Average return on equity (ROE) among peers: 12694.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Barington/Hilco Acquisition (BHAC) | $4.11 Million | -9.40% | 2.37x | $90.28 Million |
| Artius II Acquisition Inc. (AACB) | $214.29 Million | 0.06% | 0.07x | $233.50 Million |
| Artius II Acquisition Inc. Units (AACBU) | $214.29 Million | 0.06% | 0.07x | $268.87 Million |
| Ares Acquisition Corporation II (AACT) | $12.50K | 126761.58% | 32.39x | $587.05 Million |
| AA Mission Acquisition Corp. (AAM) | $113.40 Million | 126.10% | 27.74x | $388.34K |
| Altenergy Acquisition Corp (AEAE) | $4.84 Million | 51.14% | 2.71x | $72.22 Million |
| Activate Energy Acquisition Corp. Class A Ordinary Share (AEAQ) | $223.53 Million | 0.00% | 0.04x | $237.16 Million |
| American Exceptionalism Acquisition Corp. A (AEXA) | $328.45 Million | 0.00% | 0.06x | $391.48 Million |
| Aimei Health Technology Co., Ltd Ordinary Share (AFJK) | $72.31 Million | 3.53% | 0.02x | $38.12 Million |
| Aifeex Nexus Acquisition Corporation (AIFE) | $86.16 Million | -0.10% | 0.01x | $91.13 Million |
| AI TRANSPORTATION ACQUISITION CORP Ordinary shares (AITR) | $60.04 Million | -0.06% | 0.02x | $86.22 Million |
About Barington/Hilco Acquisition
As of June 6, 2025, Focus Impact BH3 Acquisition Company was acquired by XCF Global Capital, Inc., in a reverse merger transaction. Focus Impact BH3 Acquisition Company does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was forme… Read more